Good, solid, 'nuts and bolts' type announcement.a biomarker patent, taking us just that much further down the road to fulfilling the promise of CAR-T - personalised targeted therapies.
Last night's turbulence on US markets just provides another good buying opportunity.
Lots of irons in the fire ...and the Company well cashed-up to carry its programs forward. Just another glorious day under the sun.
